Citation Impact
Citing Papers
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
Intensive versus Conventional Glucose Control in Critically Ill Patients
2009 Standout
Should every survivor of a heart attack be given a beta-blocker?
1982
Reduction of ventricular arrhythmias by early intravenous atenolol in suspected acute myocardial infarction.
1983
Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data
1997 Standout
Acute Coronary Care in the Elderly, Part I
2007
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
2008 Standout
Arrhythmias and mortality in congestive heart failure
1990
Effect of Beta Blockers, Particularly Carvedilol, on Reducing the Risk of Events After Acute Myocardial Infarction
2006
Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery
1996 Standout
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
2004 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
1992 Standout
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
2006 Standout
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
2003 Standout
Mortality prediction in diabetic patients with myocardial infarction: experiences from the DIGAMI study
1997
Antiarrhythmic effect of carvedilol after acute myocardial infarction
2005
Outpatient adherence to beta-blocker therapy after acute myocardial infarction
2002
Effectiveness of amiodarone on ventricular arrhythmias during and after acute myocardial infarction
1987
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
2003 Standout
Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo
1991 Standout
Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart Disease
1998 Standout
First Documented Rhythm and Clinical Outcome From In-Hospital Cardiac Arrest Among Children and Adults
2006 Standout
Fish Intake, Contaminants, and Human Health
2006 Standout
Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction
2003
Do the Results of Randomized Clinical Trials of Cardiovascular Drugs Influence Medical Practice?
1992
Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000
2007 Standout
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
2002 Standout
Management of acute myocardial infarction in patients presenting with ST-segment elevation
2003
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
Relation between beta-adrenergic blocker use, various correlates of left ventricular function and the chance of developing congestive heart failure
1990
Prognosis Among Survivors of Prehospital Cardiac Arrest
1995
Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era
2006
Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention
2007 Standout
Absence of a deleterious effect of calcium channel blockers in patients with left ventricular dysfunction after myocardial infarction: The SAVE study experience
1998
Is age an independent predictor of early and late mortality in patients with acute myocardial infarction?
1992
Interventions to Enhance Patient Adherence to Medication Prescriptions
2002 Standout
Quantifying heterogeneity in a meta‐analysis
2002 Standout
Doxorubicin-Induced Cardiomyopathy
1998 Standout
Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome
2011
Intensive Insulin Therapy in Critically Ill Patients
2001 Standout
Bias in meta-analysis detected by a simple, graphical test
1997 Standout
Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year
1995 Standout
Intensive Insulin Therapy in the Medical ICU
2006 Standout
Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview
2000 Standout
Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration
1994 Standout
PREVENTION OF VENTRICULAR FIBRILLATION DURING ACUTE MYOCARDIAL INFARCTION BY INTRAVENOUS PROPRANOLOL
1984
The Risk of Myocardial Infarction Associated With Antihypertensive Drug Therapies
1995 Standout
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
2003 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Evaluating the federal role in financing health-related research
1996 StandoutNobel
Epinephrine-induced hypokalemia: The role of beta adrenoceptors
1986
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial
2011 Standout
Effect of very early intervention with metoprolol on myocardial infarct size.
1983
Analysis and Interpretation of Treatment Effects in Subgroups of Patients in Randomized Clinical Trials
1991
Ambulatory (Holter) Electrocardiography Technology
1992
β-Blockers and Primary Prevention of Coronary Heart Disease in Patients With High Blood Pressure
1989
Hormone-electrolyte interactions in the pathogenesis of lethal cardiac arrhythmias in patients with congestive heart failure: Basis of a new physiologic approach to control of arrhythmia
1986
Blood pressure, stroke, and coronary heart disease
1990 Standout
Methods for combining randomized clinical trials: Strengths and limitations
1987
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data
2000 Standout
Beta blockade during and after myocardial infarction: An overview of the randomized trials
1985 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Coronary Plaque Disruption
1995 Standout
Overexpression of the Cardiac β2-Adrenergic Receptor and Expression of a β-Adrenergic Receptor Kinase-1 (βARK1) Inhibitor Both Increase Myocardial Contractility but Have Differential Effects on Susceptibility to Ischemic Injury
1999 StandoutNobel
Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction.
1983
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
2000 Standout
The Role of ??-Blockers in the Treatment of Cardiomyopathy and Ischaemic Heart Failure
1994
Treatment with Histamine H2Antagonists in Acute Upper Gastrointestinal Hemorrhage
1985 Standout
β2-Adrenergic Receptor Antagonists Protect Against Ventricular Fibrillation
1997
Heart Rate Variability
1996 Standout
Heart rate variability: Standards of measurement, physiological interpretation, and clinical use
1996 Standout
Effect of propranolol after acute myocardial infarction in patients with congestive heart failure.
1986
Inhibition of Adenylyl Cyclase by G iα
1993 StandoutScienceNobel
Reduction of infarct size with the early use of timolol in acute myocardial infarction
1984
Declining incidence of ventricular fibrillation in myocardial infarction. Implications for the prophylactic use of lidocaine.
1992
Release of endogenous catecholamines in the ischemic myocardium of the rat. Part A: Locally mediated release.
1984
A Long-Term Prevention Study with Oxprenolol in Coronary Heart Disease
1982
Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction
1999
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Conducting Meta-Analyses inRwith themetaforPackage
2010 Standout
Influence of Diabetes on 5-Year Mortality and Morbidity in a Randomized Trial Comparing CABG and PTCA in Patients With Multivessel Disease
1997
Expert consensus document on ?-adrenergic receptor blockersThe Task Force on Beta-Blockers of the European Society of Cardiology
2004
Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients
2000 Standout
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Complexity and contradiction in clinical trial research
1987
Works of L Rydén being referenced
Improved Physical Fitness and Quality of Life Following Training of Elderly Patients after Acute Coronary Events
2000
A Double-Blind Trial of Metoprolol in Acute Myocardial Infarction
1983
EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTION
1981
The reliability of intermittent ECG sampling in arrhythmia detection.
1975
Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart
2006
Intense metabolic control decreases long-term mortality and morbidity in diabetics with myocardial infarction
1996